CDC: Most U.S. youths consume too much sodium | Study links small weight gain with higher blood pressure | Higher blood pressure in morning may raise risks, study says
Web Version
September 11, 2014
PCNA SmartBrief
News about cardiovascular disease prevention and management

Heart Health NewsSponsored By
CDC: Most U.S. youths consume too much sodium
More than 90% of 6- to 18-year-olds consume an average of 3,300 milligrams of sodium each day, exceeding the recommended daily salt intake of less than 2,300 mg, according to a CDC report released Tuesday. About 16% of 8- to 17-year-olds have elevated blood pressure levels, but healthy diets with less sodium intake can lower this rate, researchers said. Reuters (9/9), (9/9)
Share: LinkedInTwitterFacebookGoogle+Email
Study links small weight gain with higher blood pressure
Blood pressure in healthy adults increased with just a 5- to 11-pound gain in weight, according to a study presented at an American Heart Association meeting. Researchers from Mayo Clinic in Rochester, Minn., said gaining weight in the stomach was linked to even higher blood pressure increases. (9/10)
Share: LinkedInTwitterFacebookGoogle+Email
Higher blood pressure in morning may raise risks, study says
Hypertensive patients on medication who report increased blood pressure readings in the mornings at home may be at higher risk of a cardiovascular event, according to a study in Japan reported in the journal Hypertension. The risk was evident even if patients had blood pressure readings that were within normal ranges in a clinical setting, researchers said. MedWire News (U.K.) (9/8)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Watch top cardiologists—live & online—discuss the latest advances in selecting oral antiplatelet regimens for patients with STEMI. Topics include the difference between STEMI and NSTEMI, treatment selection, and optimal dosing and loading. Register Today--It's free for clinicians.
Emerging Trends
Orexigen's weight-loss drug Contrave wins FDA approval
The FDA has approved Orexigen Therapeutics' oral drug Contrave, a combination of bupropion and naltrexone, for use in chronic weight management along with a low-calorie diet and exercise. The drug is intended for obese or overweight individuals with at least one health problem related to weight, such as diabetes. Contrave will be marketed in the U.S. by Takeda Pharmaceutical. San Diego Union-Tribune (9/10), Bloomberg Businessweek (9/11)
Share: LinkedInTwitterFacebookGoogle+Email
Data show obesity, disease disparities in U.S.
A report from the Trust for America's Health and the Robert Wood Johnson Foundation found the average American is now 24 pounds heavier than in 1960, and obesity rates were highest among black adults and Latino children compared with their white counterparts. Alabama also had the highest type 2 diabetes rate in 2013 at 13.8% of the population, while West Virginia had the highest hypertension rate at 41%, researchers added. U.S. News & World Report/Data Mine blog (9/4)
Share: LinkedInTwitterFacebookGoogle+Email
Statins may reduce cardiovascular risk in familial hypercholesterolemia
Among youths with familial hypercholesterolemia, the use of the statin drug pravastatin was associated with reduced odds of premature atherosclerosis, according to a Dutch study in the Journal of the American Medical Association. Earlier start of the treatment yielded better results, researchers said. HealthDay News (9/9)
Share: LinkedInTwitterFacebookGoogle+Email
Other News
Nursing in the News
Nurses calls for more funding to increase RN workforce
Aging baby boomers, nurse retirements and health care reform initiatives mean the U.S. will need 1.1 million new registered nurses by 2022, according to American Nurses Association. The nursing group has asked for a 12% increase in federal nursing workforce development funding for 2015 and says hospitals should hire new nurses who can gain experience from veteran RNs. Medscape (free registration) (9/5), Healthcare Dive (9/5)
Share: LinkedInTwitterFacebookGoogle+Email
PCNA Update
New on-demand ACS patient medication adherence course offered
Adherence to guidelines by health care professionals in the management of patients with acute coronary syndrome remains suboptimal despite the fact that the implementation of professional guidelines into treatment strategies has been shown to improve outcomes in patients with ACS post-hospitalization. In addition, patient adherence to therapy is also suboptimal. Clinicians can improve patient adherence by learning about patient-related factors of non-adherence to therapy and addressing those factors with their patients. Participants will learn to implement evidence-based options recommended in professional guidelines for antithrombotic therapy in ACS patients, use achieved knowledge of antithrombotic options to manage ACS patients post-hospitalization, and identify issues involving communication gaps between patient advocates and patients diagnosed with ACS. Learn more about about this exciting new course.
Share: LinkedInTwitterFacebookGoogle+Email
Familial Hypercholesterolemia Awareness Day
Sept. 24 is Familial Hypercholesterolemia Awareness Day! PCNA is working with the FH Foundation to raise awareness of familial hypercholesterolemia worldwide with the 1 Minute to Save 1 Family campaign: It only takes a minute to share information that can save a family from early heart disease. Find the one person in 200 who has inherited high cholesterol, or familial hypercholesterolemia, and you will help an entire family prevent early heart attacks caused by this common but under-recognized genetic disorder. Help the FH Foundation reach the 90% undiagnosed by sharing its media kit. Download the kit and share messages posted on our Facebook and Twitter pages leading up to FH Awareness Day.
Share: LinkedInTwitterFacebookGoogle+Email
Lead Quote
It's your outlook on life that counts. If you take yourself lightly and don't take yourself too seriously, pretty soon you can find the humor in our everyday lives. And sometimes it can be a lifesaver."
-- Betty White,
American actress
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about PCNA ->Join PCNA | News | Clinical Tools | Conferences & Programs | Contact
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
Editor:  Tom Parks
Advertising:  Rebecca Adelson
  P: 202.618.5665

Download the SmartBrief App  iTunes / Android
iTunes  Android
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2014 SmartBrief, Inc.®
Privacy policy |  Legal Information